ANTI-INSULIN ANTIBODY INCREASED

This adverse event was reported 93 times

These drugs are most commonly taken by patients reporting ANTI-INSULIN ANTIBODY INCREASED:

# Drug Count
0 INSULIN GLARGINE 28
1 INSULIN LISPRO 26
2 HUMAN INSULIN 23
3 INSULIN HUMAN 12
4 ASPIRIN 10
5 ASPIRIN 325 MG 10
6 ASPIRIN 81 MG 10
7 INSULIN GLULISINE 8
8 AMLODIPINE BESYLATE 7
9 FUROSEMIDE 7
See all common drugs associated with ANTI-INSULIN ANTIBODY INCREASED

ANTI-INSULIN ANTIBODY INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN INSULIN 23 0.0032
1 MIGLITOL 3 0.0031
2 INSULIN GLULISINE 8 0.0008
3 UREA 1 0.0005
4 SITAGLIPTIN PHOSPHATE 1 0.0004
5 INSULIN GLARGINE-YFGN 7 0.0003
6 INSULIN HUMAN 12 0.0003
7 ALOGLIPTIN 1 0.0003
8 INSULIN LISPRO 26 0.0002
9 INSULIN GLARGINE 28 0.0001
See all drugs enriched for association with ANTI-INSULIN ANTIBODY INCREASED

ANTI-INSULIN ANTIBODY INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin [EPC] 31 0.0007
1 alpha-Glucosidase Inhibitor [EPC] 3 0.0006
2 Insulin Analog [EPC] 45 0.0001
3 Sulfonylurea [EPC] 5 0.0000
4 Alkaloid [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Platelet Aggregation Inhibitor [EPC] 10 0.0000
7 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
8 Loop Diuretic [EPC] 7 0.0000
9 Aldosterone Antagonist [EPC] 2 0.0000
See all drug classes enriched for association with ANTI-INSULIN ANTIBODY INCREASED